Phase I trial of paclitaxel, carboplatin
โ
John D. Hainsworth; Howard A. Burris III; Lisa H. Morrissey; F. Anthony Greco
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 72 KB
๐ 3 views
## Background: Topotecan is a new antineoplastic agent with a broad spectrum of activity. the purpose of this phase i trial was to define the maximum tolerated dose of topotecan when added to the widely used combination of paclitaxel and carboplatin. ## Methods: Patients with advanced cancer that